Zusammenfassung
Die mediale und die laterale Epikondylopathie stellen zwar gutartige, weil in der Regel nach 1–2 Jahren selbstlimitierende Erkrankungen dar, können aber für die Betroffenen zu einer massiven Einschränkung der Lebensqualität und Arbeitsfähigkeit führen. Die Verwendung von „platelet-riched plasma“ nutzt einen biologischen Therapieansatz, bei dem, anders als bei rein antiinflammatorischen Therapien, durch eine Optimierung des Gewebsmilieus eine Regeneration und Reparation des geschädigten Sehnenansatzes angestrebt wird. Die Studienlage ist bezüglich der allgemeinen als auch hinsichtlich eines Kurz- oder Langzeiteffekts different. Die Stammzelltherapie ist ein neues und bisher kaum verwendetes Therapieverfahren. Erste Fallserien erscheinen vielversprechend. Die Stoßwellentherapie stellt eine zwar nicht neue und etablierte, aber anhaltend kontrovers diskutierte Behandlungsform bei der Epikondylopathie dar.
Abstract
Lateral and medial epicondylopathy (epicondylitis), which are common and in most cases self-limiting, frequently result in relevant reduction of quality of life and may also affect the ability to work. Recently, the use of orthobiologics, such as platelet-rich plasma (PRP), has been proposed to promote tendon regeneration and is supposed to be a valuable treatment option. However, scientific data are conflicting and the short- and long-time results are controversial. The use of stem cells is new approach and preliminary clinical data are promising. Shock wave therapy is widely used and part of the daily routine in treating lateral epicondylopoathy, although it is questionable for medial epicondylopathy.
Abbreviations
- ADSC:
-
„Adipose-derived progenitor cells“
- bFGF:
-
„Basic fibroblast growth factor“
- BMAC:
-
„Bone marrow aspirate concentrate“
- CFO:
-
„Common flexor origin“
- CSES:
-
Canadian Shoulder and Elbow Society
- DASH:
-
„Disabilities of arm, shoulder and hand”
- ECRB:
-
Musculus extensor carpi radialis brevis
- IGF:
-
„Insulin-like growth factor“
- LCL:
-
„Lateral collateral ligament“
- MSC:
-
Mesenchymale Stammzellen
- NSAR:
-
Nichtsteroidales Antirheumatikum
- PDGF:
-
„Platelet-derived growth factor“
- PDGFB:
-
„Platelet-derived growth factor subunit B“
- PRP:
-
„Platelet-riched plasma“
- PRPLP :
-
Leukozytenarmes PRP
- PRPLR :
-
Leukozytenreiches PRP
- PRTEE:
-
Patient-Rated Tennis Elbow Evaluation
- RCT:
-
Randomisierte kontrollierte Studie
- TGF:
-
„Transforming growth factor“
- VAS:
-
Visuelle Analogskala
- VEGF:
-
„Vascular endothelial growth factor“
Literatur
Alberta F (2015) CORR insights(R): does nonsurgical treatment improve longitudinal outcomes of lateral epicondylitis over no treatment? A meta-analysis. Clin Orthop Relat Res 473:1108–1110
Alessio-Mazzola M, Repetto I, Biti B et al (2018) Autologous US-guided PRP injection versus US-guided focal extracorporeal shock wave therapy for chronic lateral epicondylitis: a minimum of 2‑year follow-up retrospective comparative study. J Orthop Surg (Hong Kong) 26:2309499017749986
Alzahrani WM (2022) Platelet-rich plasma injections as an alternative to surgery in treating patients with medial epicondylitis: a systematic review. Cureus 14:e28378
Amin NH, Kumar NS, Schickendantz MS (2015) Medial epicondylitis: evaluation and management. J Am Acad Orthop Surg 23:348–355
Anitua E, Andia I, Sanchez M et al (2005) Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 23:281–286
Arirachakaran A, Sukthuayat A, Sisayanarane T et al (2016) Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis. J Orthop Traumatol 17:101–112
Ball CM, Meunier M, Galatz LM et al (2002) Arthroscopic treatment of post-traumatic elbow contracture. J Shoulder Elbow Surg 11:624–629
Bhabra G, Wang A, Ebert JR et al (2016) Lateral elbow tendinopathy: development of a pathophysiology-based treatment algorithm. Orthop J Sports Med 4:2325967116670635
Boden AL, Scott MT, Dalwadi PP et al (2019) Platelet-rich plasma versus Tenex in the treatment of medial and lateral epicondylitis. J Shoulder Elbow Surg 28:112–119
Bohlen HL, Schwartz ZE, Wu VJ et al (2020) Platelet-rich plasma is an equal alternative to surgery in the treatment of type 1 medial epicondylitis. Orthop J Sports Med 8:2325967120908952
Bosch G, de Mos M, van Binsbergen R et al (2009) The effect of focused extracorporeal shock wave therapy on collagen matrix and gene expression in normal tendons and ligaments. Equine Vet J 41:335–341
Calfee RP, Patel A, Dasilva MF et al (2008) Management of lateral epicondylitis: current concepts. J Am Acad Orthop Surg 16:19–29
Chaudhury S, de La Lama M, Adler RS et al (2013) Platelet-rich plasma for the treatment of lateral epicondylitis: sonographic assessment of tendon morphology and vascularity (pilot study). Skelet Radiol 42:91–97
Connell D, Datir A, Alyas F et al (2009) Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med 43:293–298
Coombes BK, Bisset L, Brooks P et al (2013) Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial. JAMA 309:461–469
Defoort S, De Smet L, Brys P et al (2021) Lateral elbow tendinopathy: surgery versus extracorporeal shock wave therapy. Hand Surg Rehabil 40:263–267
Dohan Ehrenfest DM, Andia I, Zumstein MA et al (2014) Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J 4:3–9
Dragoo JL, Meadows MC (2019) The use of biologics for the elbow: a critical analysis review. J Shoulder Elbow Surg 28:2053–2060
Evans JP, Maffulli N, Smith C et al (2021) Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study. J Orthop Traumatol 22:47
Ford RD, Schmitt WP, Lineberry K et al (2015) A retrospective comparison of the management of recalcitrant lateral elbow tendinosis: platelet-rich plasma injections versus surgery. Hand (N Y) 10:285–291
Glanzmann MC, Audige L (2015) Platelet-rich plasma for chronic lateral epicondylitis: is one injection sufficient? Arch Orthop Trauma Surg 135:1637–1645
Greiner S, Lawton R, Voss A (2022) Cell-based therapy of the elbow: evidence for lateral tendinopathy‑a review on current treatments. Knee Surg Sports Traumatol Arthrosc 30:1152–1160
Haake M, Konig IR, Decker T et al (2002) Extracorporeal shock wave therapy in the treatment of lateral epicondylitis : a randomized multicenter trial. J Bone Joint Surg Am 84:1982–1991
Hardy R, Tori A, Fuchs H et al (2021) To improve pain and function, platelet-rich plasma injections may be an alternative to surgery for treating lateral epicondylitis: a systematic review. Arthroscopy 37:3360–3367
Hastie G, Soufi M, Wilson J et al (2018) Platelet rich plasma injections for lateral epicondylitis of the elbow reduce the need for surgical intervention. J Orthop 15:239–241
Houck DA, Kraeutler MJ, Thornton LB et al (2019) Treatment of lateral epicondylitis with autologous blood, platelet-rich plasma, or corticosteroid injections: a systematic review of overlapping meta-analyses. Orthop J Sports Med 7:2325967119831052
Karaduman M, Okkaoglu MC, Sesen H et al (2016) Platelet-rich plasma versus open surgical release in chronic tennis elbow: a retrospective comparative study. J Orthop 13:10–14
Kemp JA, Olson MA, Tao MA et al (2021) Platelet-rich plasma versus corticosteroid injection for the treatment of lateral epicondylitis: a systematic review of systematic reviews. Int J Sports Phys Ther 16:597–605
Kia C, Baldino J, Bell R et al (2018) Platelet-rich plasma: review of current literature on its use for tendon and ligament pathology. Curr Rev Musculoskelet Med 11:566–572
Krischek O, Hopf C, Nafe B et al (1999) Shock-wave therapy for tennis and golfer’s elbow—1 year follow-up. Arch Orthop Trauma Surg 119:62–66
Krischek O, Rompe JD, Hopf C et al (1998) Extracorporeal shockwave therapy in epicondylitis humeri ulnaris or radialis—a prospective, controlled, comparative study. Z Orthop Ihre Grenzgeb 136:3–7
Krogh TP, Bartels EM, Ellingsen T et al (2013) Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials. Am J Sports Med 41:1435–1446
Krogh TP, Fredberg U, Stengaard-Pedersen K et al (2013) Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med 41:625–635
Lapner P, Alfonso A, Hebert-Davies J et al (2022) Nonoperative treatment of lateral epicondylitis: a systematic review and meta-analysis. JSES Int 6:321–330
Lapner P, Alfonso A, Herbert-Davies J et al (2022) Position statement: nonoperative management of lateral epicondylitis in adults. Can J Surg 65:E625–E629
Lee SS, Kang S, Park NK et al (2012) Effectiveness of initial extracorporeal shock wave therapy on the newly diagnosed lateral or medial epicondylitis. Ann Rehabil Med 36:681–687
Lee SY, Kim W, Lim C et al (2015) Treatment of lateral epicondylosis by using allogeneic adipose-derived mesenchymal stem cells: a pilot study. Stem Cells 33:2995–3005
Lim W, Park SH, Kim B et al (2018) Relationship of cytokine levels and clinical effect on platelet-rich plasma-treated lateral epicondylitis. J Orthop Res 36:913–920
Mazzocca AD, Mccarthy MB, Intravia J et al (2013) An in vitro evaluation of the anti-inflammatory effects of platelet-rich plasma, ketorolac, and methylprednisolone. Arthroscopy 29:675–683
Merolla G, Dellabiancia F, Ricci A et al (2017) Arthroscopic debridement versus platelet-rich plasma injection: a prospective, randomized, comparative study of chronic lateral epicondylitis with a nearly 2‑year follow-up. Arthroscopy 33:1320–1329
Molloy T, Wang Y, Murrell G (2003) The roles of growth factors in tendon and ligament healing. Sports Med 33:381–394
Moretti B, Iannone F, Notarnicola A et al (2008) Extracorporeal shock waves down-regulate the expression of interleukin-10 and tumor necrosis factor-alpha in osteoarthritic chondrocytes. BMC Musculoskelet Disord 9:16
Morrey B (2014) Master techniques in orthopaedic surgery: the elbow. Lippincott Williams Wilkins
Muthu S, Patel S, Selvaraj P et al (2021) Comparative analysis of leucocyte poor vs leucocyte rich platelet-rich plasma in the management of lateral epicondylitis: systematic review meta-analysis of randomised controlled trials. J Clin Orthop Trauma 19:96–107
Niemiec P, Szyluk K, Balcerzyk A et al (2021) Why PRP works only on certain patients with tennis elbow? Is PDGFB gene a key for PRP therapy effectiveness? A prospective cohort study. BMC Musculoskelet Disord 22:710
O’dwyer KJ, Howie CR (1995) Medial epicondylitis of the elbow. Int Orthop 19:69–71
Olaussen M, Holmedal O, Lindbaek M et al (2013) Treating lateral epicondylitis with corticosteroid injections or non-electrotherapeutical physiotherapy: a systematic review. BMJ Open 3:e3564
Paoletta M (2022) Are autologous whole blood or platelet-rich plasma (PRP) injection effective and safe for lateral elbow pain?—A Cochrane Review summary with commentary. J Musculoskelet Neuronal Interact 22:428–430
Paramanantham M, Seenappa H, Venkataraman S et al (2022) Functional outcome of platelet-rich plasma (PRP) intra-lesional injection for tennis elbow—a prospective cohort study. Cureus 14:e22974
Park GY, Kwon DR, Cho HK et al (2017) Distribution of platelet-rich plasma after ultrasound-guided injection for chronic elbow tendinopathies. J Sports Sci Med 16:1–5
Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Radwan YA, Elsobhi G, Badawy WS et al (2008) Resistant tennis elbow: shock-wave therapy versus percutaneous tenotomy. Int Orthop 32:671–677
Rodik T, Mcdermott B (2016) Platelet-rich plasma compared with other common injection therapies in the treatment of chronic lateral epicondylitis. J Sport Rehabil 25:77–82
Rompe JD, Decking J, Schoellner C et al (2004) Repetitive low-energy shock wave treatment for chronic lateral epicondylitis in tennis players. Am J Sports Med 32:734–743
Sahbaz T, Medin Ceylan C, Karacay BC et al (2021) Comparison of platelet-rich plasma and extracorporeal shock wave therapy in patients with chronic lateral epicondylitis: a prospective, randomized-controlled study. Turk J Phys Med Rehabil 67:490–501
Savnik A, Jensen B, Norregaard J et al (2004) Magnetic resonance imaging in the evaluation of treatment response of lateral epicondylitis of the elbow. Eur Radiol 14:964–969
Sayegh ET, Strauch RJ (2015) Does nonsurgical treatment improve longitudinal outcomes of lateral epicondylitis over no treatment? A meta-analysis. Clin Orthop Relat Res 473:1093–1107
Shiri R, Viikari-Juntura E, Varonen H et al (2006) Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol 164:1065–1074
Sims SE, Miller K, Elfar JC et al (2014) Non-surgical treatment of lateral epicondylitis: a systematic review of randomized controlled trials. Hand (N Y) 9:419–446
Singh A, Gangwar DS, Singh S (2014) Bone marrow injection: a novel treatment for tennis elbow. J Nat Sci Biol Med 5:389–391
Smidt N, Lewis M, Da VDW et al (2006) Lateral epicondylitis in general practice: course and prognostic indicators of outcome. J Rheumatol 33:2053–2059
Smidt N, van der Windt DA, Assendelft WJ et al (2002) Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet 359:657–662
Staples MP, Forbes A, Ptasznik R et al (2008) A randomized controlled trial of extracorporeal shock wave therapy for lateral epicondylitis (tennis elbow). J Rheumatol 35:2038–2046
Stasinopoulos D (2018) Can extracorporeal shock-wave therapy be used for the management of lateral elbow tendinopathy? World J Methodol 8:37–39
Suresh SP, Ali KE, Jones H et al (2006) Medial epicondylitis: is ultrasound guided autologous blood injection an effective treatment? Br J Sports Med 40:935–939 (discussion 939)
Suzuki T, Hayakawa K, Nakane T et al (2022) Repeated magnetic resonance imaging at 6 follow-up visits over a 2-year period after platelet-rich plasma injection in patients with lateral epicondylitis. J Shoulder Elbow Surg 31:1581–1587
Trentini R, Mangano T, Repetto I et al (2015) Short- to mid-term follow-up effectiveness of US-guided focal extracorporeal shock wave therapy in the treatment of elbow lateral epicondylitis. Musculoskelet Surg 99(1):S91–97
Yao G, Chen J, Duan Y et al (2020) Efficacy of extracorporeal shock wave therapy for lateral epicondylitis: a systematic review and meta-analysis. Biomed Res Int 2020:2064781
Yoon SY, Kim YW, Shin IS et al (2020) Does the type of extracorporeal shock therapy influence treatment effectiveness in lateral epicondylitis? A systematic review and meta-analysis. Clin Orthop Relat Res 478:2324–2339
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
K. Schmidt-Horlohé gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von dem Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Schmidt-Horlohé, K. Therapie der lateralen und medialen Epikondylopathie. Orthopädie 52, 371–378 (2023). https://doi.org/10.1007/s00132-023-04372-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00132-023-04372-8